FCA Venture Partners
FCA Venture Partners is a healthcare-exclusive venture capital firm founded in 1996, investing Seed through Series B equity ($2-8M per company) into healthcare technology and tech-enabled services across Providers, Payers, Pharma, and Innovative Care Delivery, with approximately $335M cumulatively raised across 60+ portfolio investments.
- Company typePrivate
- Founded1996
- HeadquartersBrentwood, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What FCA Venture Partners does
FCA Venture Partners is a healthcare-exclusive venture capital firm founded in 1996 and headquartered in Nashville, Tennessee, with a secondary office in Charlotte, North Carolina. The firm invests Seed through Series B equity capital into healthcare technology and technology-enabled services companies across four sectors: Providers, Payers, Pharma, and Innovative Care Delivery. FCA targets companies with 50%+ annual growth rates and $500K-$10M in annualized revenue, deploying $2-8M per company from its general-purpose funds (most recently Fund VII, $90M oversubscribed May 2023) and $500K-$3M per company from its dedicated healthcare innovation vehicle (Health Innovations II, $71M oversubscribed January 2023). Cumulative capital raised across the firm's fund vintages totals approximately $335M, with 60+ healthcare investments made since founding.
FCA's economic model is standard venture capital fund management — earning management fees on committed/invested capital under management and carried interest on successful portfolio exits. The firm reports eight successful exits since 2020 driving $100M in exit value, with 100%+ return of investor capital in FCA V and Health Innovations I as of 2021. Portfolio companies have subsequently raised more than $200M in follow-on capital from growth and strategic investors.
FCA's competitive differentiation is built on a strategic partner network of 12+ named healthcare organizations including major health systems (Advocate Health, WakeMed, Tampa General Hospital, Novant Health, ECU Health, Cone Health, St. Francis), a payer (BCBS NC), and industry partners (Laerdal). The firm positions itself as an active board-level investor providing strategic advice, customer introductions to health systems and payers, recruiting support, and CEO-to-CEO connections across its portfolio. The 11-person team is led by Managing Partners Matt King, Andrew Bouldin, and John Burch, with deal sourcing led by Bouldin who reviews 400+ investment opportunities annually.
FCA Venture Partners firmographics
Firmographics- Name
- FCA Venture Partners
- Legal name
- FCA Venture Partners
- Website
- https://fcavp.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- FCA Venture Partners is a healthcare-exclusive venture capital firm founded in 1996, investing Seed through Series B equity ($2-8M per company) into healthcare technology and tech-enabled services across Providers, Payers, Pharma, and Innovative Care Delivery, with approximately $335M cumulatively raised across 60+ portfolio investments.
- Ownership category
- akta.pro rank
FCA Venture Partners industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where FCA Venture Partners is headquartered
LocationHeadquarters
- HQ city
- Brentwood
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
FCA Venture Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel
Revenue model
- Venture Fund Capital Management: Manages multiple venture capital funds (e.g., Fund VII closed at $90M oversubscribed; Health Innovations II Fund closed at $71M oversubscribed). Earns management fees on assets under management and carried interest on successful exits. Has returned 100%+ of investor capital in FCA V and FCA Health Innovations I.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Seed to Series A/B equity investment: $2–8M per company |
Go-to-market motion3 records
Distribution channels1 record
Marketing channels4 records
FCA Venture Partners product offering
Product offeringCore offering
FCA Venture Partners is a healthcare-focused venture capital firm that invests $2–8 million per company in early-stage (Seed through Series A/B) healthcare technology and technology-enabled services companies across four verticals: Providers, Payers, Pharma, and Innovative Care Delivery. The firm operates multiple limited-partner-backed funds (most recently Fund VII at $90M and Health Innovations II at $71M) and supplements capital with active board-level support, customer introductions through its strategic partner network, recruiting assistance, and capital formation guidance.
Product overview
FCA Venture Partners is a healthcare-focused venture capital firm (not a software product company) operating multiple distinct investment vehicles, most notably Fund VII (closed at $90 million) and Health Innovations Fund II (closed at $71 million), along with prior generation funds. These fund products together form a single platform-plus-modules architecture where the core platform is the firm's general venture investing capability and the dedicated modules are the healthcare-innovation-specific vehicles. Beyond capital deployment, FCA's offerings include Value-Add Portfolio Services (board-level support, strategic advice, customer introductions, recruiting, and capital formation assistance) and the FCA Strategic Partner Network, which provides portfolio companies with validated access to leading health systems, payers, and industry partners such as Advocate Health, WakeMed, TGH, St. Francis, OrthoCarolina, Novant Health, Laerdal, ECU Health, Cone Health, and BCBS NC. Limited partners access fund information via the Juniper Square-hosted FCA Venture Partners Investor Portal. Investment activity is concentrated across four healthcare sectors: Providers, Payers, Pharma, and Innovative Care Delivery.
Differentiator
Problem solved
Functional benefit
Brands
- FCA Health Innovations: Distinct venture capital fund brand within FCA Venture Partners investing $500K-$3M in Seed to Series A healthcare technology and technology-enabled services companies.
Products and services
- FCA Venture Partners Fund VII
- FCA Health Innovations Fund II
- FCA Value-Add Portfolio Services
Quantifiable outcome
- 60+ healthcare investments since founding
- +5 more outcomes
Companies that use FCA Venture Partners
Customer profileSegments5 records
Ideal customer profiles2 records
FCA Venture Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
FCA Venture Partners partnerships and signals
Strategic signalScale indicators9 records
Recent moves8 records
Expansion highlights6 records
FCA Venture Partners competitors and assessment
Company assessmentDirect peers
- Altitude Ventures: Nashville-based early-stage healthcare venture capital firm investing across digital health, healthcare services, and medical devices. Directly comparable as a healthcare-specialist VC of similar size and stage focus, sharing FCA's Nashville ecosystem roots.
- LRVHealth: Early-stage healthcare venture capital firm investing exclusively in healthcare systems, payer/provider, and digital health infrastructure. Comparable as an early-stage healthcare specialist with strategic LP/partnership orientation similar to FCA.
- Hatteras Venture Partners: Durham, NC-based venture capital firm investing in early-stage healthcare and life sciences companies. Directly comparable as a Southeast US healthcare-focused Seed/Series A investor; Hatteras has even co-led rounds with FCA (e.g., GoCheck Kids).
- Ascension Ventures: Healthcare system-affiliated venture capital firm backed by 13+ U.S. health systems, investing across healthcare IT, services, and medical devices. Comparable in its health system strategic partner model and healthcare-only thesis, mirroring FCA's 12 strategic partners approach.
- Echo Health Ventures: Strategic healthcare venture capital firm formed by Cambia Health Solutions and Mosaic Health Solutions. Comparable as a healthcare-focused VC with strategic partner backing and portfolio support model; has co-invested alongside FCA (Vericred Series B).
- MARTIN Ventures: Nashville-based venture capital firm investing in healthcare technology and tech-enabled services. Directly comparable as a healthcare-focused VC anchored in the Nashville ecosystem; has co-invested with FCA (Integrative Health Centers Seed).
- 7wireVentures: Early-stage digital health venture capital firm focused on consumer-oriented health and wellness, care delivery, and health IT. Comparable as a healthcare-exclusive early-stage investor; similar thesis-driven approach to digital health and innovative care delivery.
- Health Catalyst Capital: Healthcare-focused venture capital firm investing in growth-stage healthcare technology and tech-enabled services companies. Comparable as a healthcare-specialist VC with thesis-driven sub-sector focus similar to FCA.
Broad incumbents
- Andreessen Horowitz: Large multi-stage venture capital firm with a dedicated bio/health fund investing across digital health, biotech, and healthcare services. Comparable as a healthcare investor but operates as a generalist platform with healthcare as one major vertical among many.
- Bessemer Venture Partners: Large multi-stage venture capital firm with a substantial healthcare practice spanning healthcare IT, biotech, and services. Comparable as a healthcare investor but operates at far greater scale across all stages and geographies, with healthcare as one of several verticals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
FCA Venture Partners social profiles
Digital presenceFCA Venture Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
FCA Venture Partners leadership team
Management profileNumber of profiles
Profiles13 records
FCA Venture Partners subsidiaries and ownership
Company hierarchySubsidiaries1 record
FCA Venture Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FCA Venture Partners M&A and investment
M&A and investmentM&A
Investments88 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FCA Venture Partners
What does FCA Venture Partners do?
FCA Venture Partners is a healthcare-focused venture capital firm that invests $2–8 million per company in early-stage (Seed through Series A/B) healthcare technology and technology-enabled services companies across four verticals: Providers, Payers, Pharma, and Innovative Care Delivery. The firm operates multiple limited-partner-backed funds (most recently Fund VII at $90M and Health Innovations II at $71M) and supplements capital with active board-level support, customer introductions through its strategic partner network, recruiting assistance, and capital formation guidance.
Is FCA Venture Partners a public or private company?
FCA Venture Partners is a private company. It is classified as management employee owned and is currently operating.
When was FCA Venture Partners founded?
FCA Venture Partners was founded in 1996. It employs 1 to 10 people.
Where is FCA Venture Partners based?
FCA Venture Partners is headquartered in Brentwood, United States, in the North America region.
How does FCA Venture Partners make money?
One revenue line is on record: venture Fund Capital Management.
Who are FCA Venture Partners's main competitors?
Direct peers on record are Altitude Ventures, LRVHealth, Hatteras Venture Partners, Ascension Ventures, Echo Health Ventures, MARTIN Ventures, 7wireVentures and Health Catalyst Capital. Broad incumbents are Andreessen Horowitz and Bessemer Venture Partners.
Does FCA Venture Partners have an API?
No public API is recorded for FCA Venture Partners.
What industry is FCA Venture Partners in?
FCA Venture Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.